既存糖尿病与成人脓毒症患者全因死亡率:一项基于人群的队列研究
该研究为基于加拿大安大略省(2008-2019年)的人口队列研究,纳入503,455例首次脓毒症相关住院的成人患者,36%有既存糖尿病(1型或2型),平均年龄73岁,54%为女性。主要结局为90天全因死亡,次要结局为有创机械通气和新发肾脏替代治疗。经基线特征标准化调整后,既存糖尿病与90天全因死亡风险降低相关(RR 0.81;95%CI 0.80-0.82),与新发肾脏替代治疗风险升高相关(RR 1.53;95%CI 1.46-1.60),与有创机械通气无显著关联(RR 1.03;95%CI 1.00-1.05)。21%(95%CI 19-28)的死亡风险降低由既往二甲双胍使用介导。作者结论认为既存糖尿病与脓毒症成人患者较低全因死亡风险和较高新发肾脏替代治疗风险相关,未来研究应评估这些关联的潜在机制。
要点
- 在503,455例首次脓毒症相关住院成人中,36%有既存糖尿病,既存糖尿病与90天全因死亡风险降低相关(调整RR 0.81;95%CI 0.80-0.82)。
- 既存糖尿病与新发肾脏替代治疗风险升高相关(调整RR 1.53;95%CI 1.46-1.60)。
- 既存糖尿病与有创机械通气无显著关联(调整RR 1.03;95%CI 1.00-1.05)。
- 21%(95%CI 19-28)的既存糖尿病与全因死亡风险降低的关联由既往二甲双胍使用介导。
- 作者结论认为未来研究应评估这些关联的潜在机制。
适用人群与场景
- 加拿大安大略省(2008-2019年)18岁及以上、首次脓毒症相关住院的成人患者。
研究设计与关键结果
- 研究类型:基于人群的队列研究;纳入503,455例首次脓毒症相关住院成人,36%有既存糖尿病(1型或2型),平均年龄73岁,54%为女性。
- 主要结局:既存糖尿病与90天全因死亡风险降低相关(调整RR 0.81;95%CI 0.80-0.82)。
- 次要结局:既存糖尿病与新发肾脏替代治疗风险升高相关(调整RR 1.53;95%CI 1.46-1.60);与有创机械通气无显著关联(调整RR 1.03;95%CI 1.00-1.05)。
- 中介分析:21%(95%CI 19-28)的既存糖尿病与全因死亡风险降低的关联由既往二甲双胍使用介导。
证据类型、等级与局限
- 证据类型:基于人群的队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: We assessed the association of preexisting diabetes mellitus with all-cause mortality and organ support receipt in adult patients with sepsis.
DESIGN: Population-based cohort study.
SETTING: Ontario, Canada (2008-2019).
POPULATION: Adult patients (18 yr old or older) with a first sepsis-related hospitalization episode.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: The main exposure of interest was preexisting diabetes (either type 1 or 2). The primary outcome was all-cause mortality by 90 days; secondary outcomes included receipt of invasive mechanical ventilation and new renal replacement therapy. We report adjusted (for baseline characteristics using standardization) risk ratios (RRs) alongside 95% CIs. A main secondary analysis evaluated the potential mediation by prior metformin use of the association between preexisting diabetes and all-cause mortality following sepsis. Overall, 503,455 adults with a first sepsis-related hospitalization episode were included; 36% had preexisting diabetes. Mean age was 73 years, and 54% of the cohort were females. Preexisting diabetes was associated with a lower adjusted risk of all-cause mortality at 90 days (RR, 0.81; 95% CI, 0.80-0.82). Preexisting diabetes was associated with an increased risk of new renal replacement therapy (RR, 1.53; 95% CI, 1.46-1.60) but not invasive mechanical ventilation (RR, 1.03; 95% CI, 1.00-1.05). Overall, 21% (95% CI, 19-28) of the association between preexisting diabetes and reduced risk of all-cause mortality was mediated by prior metformin use.
CONCLUSIONS: Preexisting diabetes is associated with a lower risk of all-cause mortality and higher risk of new renal replacement therapy among adult patients with sepsis. Future studies should evaluate the underlying mechanisms of these associations.
参考来源
- Angriman F, Saoraya J, Lawler PR, et al. Preexisting Diabetes Mellitus and All-Cause Mortality in Adult Patients With Sepsis: A Population-Based Cohort Study. Crit Care Explor. 2024. PMID: 38709081. doi:10.1097/CCE.0000000000001085
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。